Can-Fite Biopharma (CANF) Operating Margin (2010 - 2025)
Can-Fite Biopharma (CANF) operating margin from Sep 30, 2010 to Jun 30, 2025. The current Can-Fite Biopharma (CANF) operating margin is -2450.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Can-Fite Biopharma (CANF)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -2446.34% | +101.61% |
| 2024 | -1213.43% | +9.64% |
| 2023 | -1106.76% | -11.24% |
| 2022 | -1246.91% | -17.46% |
| 2021 | -1510.59% | -18.81% |
| 2020 | -1860.53% | +214.48% |
| 2019 | -591.63% | +317.75% |
| 2018 | -141.62% | -83.88% |
| 2017 | -878.57% | -82.69% |
| 2016 | -5076.47% | +26.52% |
| 2015 | -4012.50% | +698.93% |
| 2013 | -502.23% | -50.62% |
| 2011 | -1017.02% | +102.86% |
| 2010 | -501.33% | N/A |
Comparison Can-Fite Biopharma (CANF) operating margin with competitors
Can-Fite Biopharma (CANF) operating margin is -2450.00%.